pageInfo({
    time : "1261455808743"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "USN0730833020080508"
	        , headline : "FDA sets panel review of Glaxo clotting drug-Amgen"
	        , keywords : "[United States of America, Biotechnology, Chemicals, Pharmaceuticals (sub-industry), Pharmaceuticals - generic and speciality, United Kingdom, Western Europe, Europe, Healthcare, Pharmaceuticals and biotechnology, Regulation and enforcement, Economic news, EC, business/financial pages]"
	        , tickers : "[AMGN.O, us;GLAX, us;AMGN, mx;GSKN, mx;AMGN, us;GSK, gb;GSK, gb;AP47, de;GS7, ch;AMGN, GSK.L]"
	    }
	    , channel : {
	        id : "54"
	        , name : "companyNews"
	        , title : "Company News"
	    }})